NO984761D0 - Aminoisokinoliner og aminotienopyridinderivater og deres anvendelse som antiinflammatoriske midler - Google Patents

Aminoisokinoliner og aminotienopyridinderivater og deres anvendelse som antiinflammatoriske midler

Info

Publication number
NO984761D0
NO984761D0 NO984761A NO984761A NO984761D0 NO 984761 D0 NO984761 D0 NO 984761D0 NO 984761 A NO984761 A NO 984761A NO 984761 A NO984761 A NO 984761A NO 984761 D0 NO984761 D0 NO 984761D0
Authority
NO
Norway
Prior art keywords
aminotienopyridine
aminoisoquinolines
derivatives
inflammatory agents
inflammatory
Prior art date
Application number
NO984761A
Other languages
English (en)
Other versions
NO984761L (no
Inventor
Peter Hamley
James Mcdonald
James Matz
Alan Tinker
Original Assignee
Astra Pharma Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9607717.7A external-priority patent/GB9607717D0/en
Priority claimed from GBGB9608678.0A external-priority patent/GB9608678D0/en
Priority claimed from GBGB9610892.3A external-priority patent/GB9610892D0/en
Application filed by Astra Pharma Prod filed Critical Astra Pharma Prod
Publication of NO984761D0 publication Critical patent/NO984761D0/no
Publication of NO984761L publication Critical patent/NO984761L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/0803Compounds with Si-C or Si-Si linkages
    • C07F7/081Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/0803Compounds with Si-C or Si-Si linkages
    • C07F7/081Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
    • C07F7/0812Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring
    • C07F7/0814Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring said ring is substituted at a C ring atom by Si

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO984761A 1996-04-13 1998-10-12 Aminoisokinoliner og aminotienopyridinderivater og deres anvendelse som antiinflammatoriske midler NO984761L (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB9607717.7A GB9607717D0 (en) 1996-04-13 1996-04-13 Pharmaceutically active comounds
GBGB9608678.0A GB9608678D0 (en) 1996-04-26 1996-04-26 Pharmaceuticlly active compounds
GBGB9610892.3A GB9610892D0 (en) 1996-05-24 1996-05-24 Pharmaceutically active compounds
PCT/SE1997/000589 WO1997038977A1 (en) 1996-04-13 1997-04-09 Aminoisoquinolines and aminothienopyridine derivatives and their use as anti-inflammatory agents

Publications (2)

Publication Number Publication Date
NO984761D0 true NO984761D0 (no) 1998-10-12
NO984761L NO984761L (no) 1998-12-14

Family

ID=27268241

Family Applications (1)

Application Number Title Priority Date Filing Date
NO984761A NO984761L (no) 1996-04-13 1998-10-12 Aminoisokinoliner og aminotienopyridinderivater og deres anvendelse som antiinflammatoriske midler

Country Status (21)

Country Link
US (1) US6063789A (no)
EP (1) EP0892784A1 (no)
JP (1) JP2000509028A (no)
KR (1) KR20000005388A (no)
CN (1) CN1221407A (no)
AR (1) AR006619A1 (no)
AU (1) AU706110B2 (no)
BR (1) BR9708607A (no)
CA (1) CA2251681A1 (no)
CZ (1) CZ327698A3 (no)
EE (1) EE9800339A (no)
HU (1) HUP9901739A3 (no)
ID (1) ID16575A (no)
IL (1) IL126476A0 (no)
IS (1) IS4862A (no)
NO (1) NO984761L (no)
NZ (1) NZ331932A (no)
PL (1) PL329308A1 (no)
SK (1) SK134698A3 (no)
TR (1) TR199802060T2 (no)
WO (1) WO1997038977A1 (no)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69830410T2 (de) 1997-08-29 2006-01-26 Tularik Ltd. Meta-benzamidinderivate als serinprotease-inhibitoren
WO1999011622A1 (en) * 1997-09-03 1999-03-11 Guilford Pharmaceuticals Inc. Amino-substituted compounds, methods, and compositions for inhibiting parp activity
EP1100789B1 (de) 1998-07-24 2005-02-09 Bayer CropScience AG Substituierte benzoylcyclohexandione
IT1302677B1 (it) 1998-10-15 2000-09-29 Zambon Spa Derivati benzazinici inibitori della fosfodiesterasi 4
TW575567B (en) * 1998-10-23 2004-02-11 Akzo Nobel Nv Serine protease inhibitor
SE9901530D0 (sv) * 1999-04-28 1999-04-28 Astra Pharma Prod Novel compounds
DE19920791A1 (de) 1999-05-06 2000-11-09 Bayer Ag Substituierte Benzoylisoxazole
DE19921424A1 (de) 1999-05-08 2000-11-09 Bayer Ag Substituierte Benzoylketone
DE19946853A1 (de) 1999-09-30 2001-04-05 Bayer Ag Substituierte Arylketone
TW591031B (en) * 2000-02-29 2004-06-11 Takeda Chemical Industries Ltd Thienopyridine derivatives, their production and use
US7012098B2 (en) * 2001-03-23 2006-03-14 Pharmacia Corporation Inhibitors of inducible nitric oxide synthase for chemoprevention and treatment of cancers
ES2572263T3 (es) 2005-10-25 2016-05-31 Shionogi & Co Derivados de dihidrooxazina y tetrahidropirimidina como inhibidores de BACE 1
TW200804290A (en) * 2005-11-15 2008-01-16 Astrazeneca Ab Compounds and uses thereof
EP2151435A4 (en) 2007-04-24 2011-09-14 Shionogi & Co PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ALZHEIMER'S DISEASE
EP2147914B1 (en) 2007-04-24 2014-06-04 Shionogi&Co., Ltd. Aminodihydrothiazine derivatives substituted with cyclic groups
KR101324426B1 (ko) 2008-06-13 2013-10-31 시오노기세야쿠 가부시키가이샤 β 세크레타제 저해 작용을 갖는 황 함유 복소환 유도체
EP2360155A4 (en) 2008-10-22 2012-06-20 Shionogi & Co 2-AMINOPYRIDIN-4-ON AND 2-AMINOPYRIDINE DERIVATIVE WITH BACE1-HEMDERING EFFECT
CN102834384A (zh) 2009-12-11 2012-12-19 盐野义制药株式会社 *嗪衍生物
CN101863900B (zh) * 2010-06-29 2012-07-25 天津药物研究院 一氧化氮供体型噻吩并吡啶衍生物、其制备方法和用途
US9018219B2 (en) 2010-10-29 2015-04-28 Shionogi & Co., Ltd. Fused aminodihydropyrimidine derivative
WO2012057248A1 (ja) 2010-10-29 2012-05-03 塩野義製薬株式会社 ナフチリジン誘導体
EP2703399A4 (en) 2011-04-26 2014-10-15 Shionogi & Co OXAZINE DERIVATIVE AND BACE-1 HEMMER THEREOF
WO2014065434A1 (en) 2012-10-24 2014-05-01 Shionogi & Co., Ltd. Dihydrooxazine or oxazepine derivatives having bace1 inhibitory activity

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3663550A (en) * 1968-12-25 1972-05-16 Shionogi & Co 2-lower alkyl-2,3-dihydrothieno(3,2-c)quinoline oxides
US3903095A (en) * 1972-02-18 1975-09-02 Merck & Co Inc Certain substituted-thieno{8 3,2-c{9 -pyridines
GB1379111A (en) * 1972-04-13 1975-01-02 Aspro Nicholas Ltd Preparation of fused-ring pyridine and pyrazine derivatives
US4127720A (en) * 1977-09-21 1978-11-28 Bristol-Myers Company Pyrimido[2,1-a]isoquinoline derivatives having antiallergy activity
JPH04348326A (ja) * 1990-07-09 1992-12-03 Sumitomo Electric Ind Ltd 有機非線形光学材料
CN1077886C (zh) * 1993-10-21 2002-01-16 G·D·瑟尔公司 用作一氧化一氮合酶抑制剂的脒基衍生物

Also Published As

Publication number Publication date
JP2000509028A (ja) 2000-07-18
AU706110B2 (en) 1999-06-10
IS4862A (is) 1998-10-07
WO1997038977A1 (en) 1997-10-23
PL329308A1 (en) 1999-03-15
IL126476A0 (en) 1999-08-17
NO984761L (no) 1998-12-14
HUP9901739A2 (hu) 1999-09-28
SK134698A3 (en) 1999-06-11
AR006619A1 (es) 1999-09-08
EE9800339A (et) 1999-04-15
EP0892784A1 (en) 1999-01-27
ID16575A (id) 1997-10-16
BR9708607A (pt) 1999-08-03
TR199802060T2 (xx) 1999-01-18
AU2655097A (en) 1997-11-07
CA2251681A1 (en) 1997-10-23
CN1221407A (zh) 1999-06-30
US6063789A (en) 2000-05-16
CZ327698A3 (cs) 1999-05-12
HUP9901739A3 (en) 2000-06-28
KR20000005388A (ko) 2000-01-25
NZ331932A (en) 2000-02-28

Similar Documents

Publication Publication Date Title
NO984761D0 (no) Aminoisokinoliner og aminotienopyridinderivater og deres anvendelse som antiinflammatoriske midler
DK0906292T3 (da) Triazolylmercaptider og deres anvendelse som mikrobicider
NO985977D0 (no) Spiro-piperidinderivater og deres anvendelse som terapeutiske midler
NO991922L (no) Heteroarylsuccinamider og deres anvendelse som metalloproteinaseinhibitorer
DK1216247T3 (da) Imidazoimidazoler og triazoler som anti-inflammatoriske midler
DK1204649T3 (da) Arylmethylcarbonylaminothiazolderivater og deres anvendelse som antitumormidler
NO972983L (no) Sulfonamider og deres anvendelse
ATE237580T1 (de) 5-alkyl-2-arylaminophenylessigsäure und derivative
DE69735712D1 (de) Aryl-pyrimidin-derivate
DK0891332T3 (da) 6-phenylpyridyl-2-aminderivater
DK1015434T3 (da) Ny pyrimidin-4-on og pyrimidin-4-thion som fungicid
NO992725D0 (no) 6-Fenylpyridyl-2-amin-derivater anvendelige som NOS-inhibitorer
NO973338D0 (no) N-(4-aryl-tiazol-2-yl)-sulfonamid-derivater og deres anvendelse
NO971811D0 (no) Bicykliske tetrahydropyrazolopyridiner og deres anvendelse som legemidler
NO994510L (no) Substituerte isokinolin-derivater og deres anvendelse som antikonvulsanter
DE69732576D1 (de) Tetrahydrobenzindolon-derivate
NO995513L (no) N-triazolyl-2-indolkarboksamider og deres anvendelse som CCK-
DK0764157T3 (da) Benzopyraner og deres anvendelse som terapeutiske midler
NO985891D0 (no) Substituerte benzamid-derivater og deres anvendelse som antikonvulsjonsmidler
EE9900182A (et) 2-metoksüfenüülpiperasiini derivaadid
NO20013085D0 (no) Fosfororganiske forbindelser og deres anvendelse
NO972256D0 (no) O-Benzyloksimeterderivater og deres anvendelse som pesticider
NO20003142L (no) Substituerte isokinolin-derivater og anvendelse derav som antikrampemidler
DE69721846D1 (de) Hosenträger
NO984921D0 (no) Tienopyridinderivater og deres anvendelse

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application